Unified clinical trial management solutions provider Cloudbyz has launched Cloudbyz EDC 2.0, its new electronic data capture (EDC) platform.
The platform has been designed for streamlining clinical research and provides a secure Cloud platform to capture, manage, and analyse data from the trials.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
This allows researchers to quickly deliver life-changing treatments.
Cloudbyz CEO Dinesh Kashyap said: “Cloudbyz EDC is a game-changer in the world of clinical research. We’ve meticulously crafted our platform to address the needs of modern clinical trials, empowering researchers to focus on delivering breakthrough treatments to patients who need them the most.
“By harnessing the power of technology, we are helping research organisations to unlock the true potential of their data and accelerate the discovery and launch of life-changing treatments.”
The Cloudbyz EDC platform combines an intuitive user interface with latest intelligent data validation, data security, real-time data monitoring, analytics, and compliance with worldwide regulatory standards.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataOrganisations can leverage the platform for optimising their research efforts and minimise manual errors while accelerating regulatory approvals.
The user-friendly interface of Cloudbyz EDC 2.0 simplifies the collection, validation, analysis, and management of real-time clinical trial data.
It provides advanced data security with encryption, access control, and audit trails that help safeguard the confidentiality of sensitive research data.
The platform also features customisable dashboards and reports, provides real-time insights into trial progress, and aids in data-driven decision-making.
Additionally, Cloudbyz EDC has the ability to manage international trials and can adapt to different complexities across phases and treatment areas.
It can also easily accommodate a large number of sites and collect clinical outcome assessment results from patients, both directly and remotely.
The platform is also fully compliant with FDA 21 CFR Part 11, GDPR, HIPAA, and other international regulatory standards.
